본문으로 건너뛰기
← 뒤로

The Therapeutic Potential of Propranolol and Other Beta-Blockers in Hyperthyroidism.

1/5 보강
International journal of molecular sciences 📖 저널 OA 100% 2021: 8/8 OA 2022: 38/38 OA 2023: 49/49 OA 2024: 103/103 OA 2025: 453/453 OA 2026: 454/454 OA 2021~2026 2025 Vol.26(17)
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
환자: hyperthyroidism, with particular emphasis on pregnant patients, the group with iatrogenic hyperthyroidism, and patients after amiodarone
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
By alleviating the symptoms associated with high doses of L-thyroxine, which are used, e.g., in. patients with thyroid cancer, β-blockers may make it possible to maintain low TSH values.

Szybiak-Skora W, Miedziaszczyk M, Szałek E, Lacka K

📝 환자 설명용 한 줄

β-blockers have found wide application in cardiology, neurology, psychiatry, anaesthesiology, and endocrinology.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Szybiak-Skora W, Miedziaszczyk M, et al. (2025). The Therapeutic Potential of Propranolol and Other Beta-Blockers in Hyperthyroidism.. International journal of molecular sciences, 26(17). https://doi.org/10.3390/ijms26178322
MLA Szybiak-Skora W, et al.. "The Therapeutic Potential of Propranolol and Other Beta-Blockers in Hyperthyroidism.." International journal of molecular sciences, vol. 26, no. 17, 2025.
PMID 40943247 ↗

Abstract

β-blockers have found wide application in cardiology, neurology, psychiatry, anaesthesiology, and endocrinology. Due to the reduction in excessive reactivity of the peripheral sympathetic nervous system, they have been used in the treatment of symptoms of hyperthyroidism. Significant efficacy in alleviating neuro-psychiatric symptoms associated with hyperthyroidism is attributed to propranolol, while cardiac symptoms are alleviated by both non-selective and cardioselective β-blockers. The aim of our study is to collect and summarise the existing knowledge on the role of β-blockers in patients with hyperthyroidism, with particular emphasis on pregnant patients, the group with iatrogenic hyperthyroidism, and patients after amiodarone. Due to their favourable safety profile, they appear to be a beneficial supplementary therapy to the treatment of hyperthyroidism in pregnant patients. β-blockers are also used in the treatment of complications of hyperthyroidism after amiodarone administration. They may influence the therapeutic process of amiodarone-induced hyperthyroidism itself, as well as being a therapeutic alternative to amiodarone in a cardiovascular context. By alleviating the symptoms associated with high doses of L-thyroxine, which are used, e.g., in. patients with thyroid cancer, β-blockers may make it possible to maintain low TSH values.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기